Pemetrexed Market Landscape And Its Growth Prospects 2018-2026

Pemetrexed Drugs

Pemetrexed is a chemotherapy drug indicated for the treatment of pleural mesothelioma and non-small cell lung cancer. Pemetrexed is a patented drug of Eli Lilly and Company and sold under brand name Alimta. In 2004, Alimta (Pemetrexed injection) was approved by FDA in combination with cisplatin as an initial treatment for patients with malignant pleural mesothelioma. In 2008, ALIMTA, in combination with cisplatin, was approved as an initial chemotherapy treatment for locally advanced or metastatic NSCLC for patients with nonsquamous histology, and in 2009, ALIMTA was approved as a maintenance therapy for locally advanced or metastatic nonsquamous non-small cell lung cancer (NSCLC).

For In depth Information Get Sample Copy of this Report at: https://bit.ly/2XqLfJr

Global Key Players:

Key players operating in the global pemetrexed market include Eli Lilly and Company, Stada Arzneimittel AG, Eagle Pharmaceuticals, Inc., and others.

Detailed Segmentation:

Global Pemetrexed Market, By Strength :
100 mg, 500 mg

Global Pemetrexed Market, By Distribution Channel:
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Global Pemetrexed Market, By Region:
North America,Europe,Asia Pacific,Latin America,Middle East,Africa

North America Is Expected To Hold Dominant Position, Owing To High Prevalence Of Non-Small Cell Lung Cancer And Its High Treatment Rate In The U.S.

According to Eli Lilly and Company’s annual report 2017, Alimta (pemetrexed) generated around 50% of its revenue from the U.S. Hence, North America is expected to be most conducive region for growth of the pemetrexed market, due to high prevalence of non-small cell lung cancer and high cost for its treatment.
For instance, according to the data published by the American Cancer Society in 2017, lung cancer (both small cell and non-small cell) is the second most common type of cancer in U.S and around 13% of all new cancers are lung cancer.

American Cancer Society also estimated that in 2019, around 228,150 new cases of lung cancer (116,440 in men and 111,710 in women) would be diagnosed in the U.S. and survival rate for non-small cell lung cancer in stage IA1 NSCLC is about 92%, stage IB NSCLC (68%), stage IIIA NSCLC (36%), stage IIIC cancers (13%), and for stage IIIC cancers (13%).

Browse Research Report At: https://bit.ly/2SxECRP


Market Dynamics:

Launch of generic version of pemetrexed in key region is expected to increase affordability of pemetrexed, which in turn is expected to support global pemetrexed market growth over the forecast period.
For instance, in July 2018, STADAPHARM GmbH, the subsidiary of STADA Arzneimittel AG launched Pemetrexed STADA generic version of Alimta in Europe.

High prevalence of non-small cell lung cancer and pleural mesothelioma is expected to rise the demand for Pemetrexed for its treatment and support global pemetrexed market growth over the forecast period.
For instance, according to the data published by American Society of Clinical Oncology, in January 2018, in the U.S. around 234,030 adults (121,680 men and 112,350 women) were diagnosed with lung cancer among which non-small cell lung cancer is the most common type of lung cancer, accounting for 80% to 85% of all lung cancer diagnose.

Inquire Here Before Purchase of Research Report @ https://bit.ly/2NwV83S

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.


Contact Us

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702

Comments

Post a Comment

Popular posts from this blog

Breast Pumps Market Surge in Demand from Healthcare Industry to Boost Growth Forecast to 2026

Image
Breast pump devices enable women to express breast milk and store it for later use. These are especially useful for working mothers nursing a newborn. Breast pumps gaining eligibility for reimbursement under the Affordable Care Act is a key trend promoting its adoption in the U.S. Working mothers usually prefer automatic electronic breast pumps. These automatic breast pumps have adjustable suction level and variable cycling time, which offers enhanced comfort to the use. Double pumps help reduce pumping time as they drain both breasts simultaneously and more effectively. Market Dynamics Increasing awareness and favorable reimbursement policies are augmenting market growth. Growing number of women in the workforce is a major factor driving demand for breast pumps. Electric breast pumps which can express more milk in a shorter time are most popular among consumers in developed economies such as the U.S. and countries in Western Europe. However, the device is not...
Read more

Booms and Busts in Anatomic Pathology Market; Dynamics Trends Over The Time Discussed 2018-2026

Image
Anatomic pathology involves direct visualization of human tissue as gross examination as well as under a microscope for proper diagnosis of the disease or a pathological condition. Subtypes of anatomic pathology include surgical pathology, oral and maxillofacial pathology, cytopathology, molecular pathology, and forensic pathology. Procedures performed in anatomic pathology include gross examination, histopathology, immunohistochemistry, in situ hybridization, cryopathology, tissue cytogenetics, and others. Standard approach in anatomical pathology is microscopic examination of tissue samples with the help of one or more stains. Manufacturers have developed stains to identify and classify microorganisms in biopsy of tissue samples or excisional specimens. Various gram stains and acid-fast stains have applications in detection of bacteria and mycobacteria in tissue samples. Commercially available products include tissue processing systems, microtomes, cryostats, ...
Read more

Negative Pressure Wound Therapy (NPWT) Devices Market Outlook and Opportunities in Grooming Regions 2026

Image
Treatment options for wounds includes application of topical medication, sutures, staples, adhesives, compression therapy, hyperbaric oxygen therapy, biological dressings, and negative pressure wound therapy (NPWT). Negative pressure wound therapy, also called vacuum-assisted wound closure, has gained significant traction over the last decade as it is equally effective in acute and chronic wounds. NPWT is a relatively non-invasive wound therapy and offers various pips other conventional treatment options by facilitating better healing, shorter hospital stay, and fewer wound infections. Get Exclusive Sample Report at: http://bit.ly/30lpsDC Market Dynamics The primary benefits of NPWT such as elimination of edema, providing a moist wound-healing environment, and stimulating angiogenesis and blood flow to the wound is increasing its uptake. Moreover, the new guidelines outlined by the World Health Organization (WHO) in November 2016, recommends use of NPWT in...
Read more